Genetics, Risk Factors & New diagnostic tools_AD_Papers published in February 2020

To receive the list of papers covered (with time-stamps), please subscribe to our mailing list. You can do so by filling this form: 

-------->  https://forms.gle/CVVbznAFM8pamdgk6  -------

or by sending us an email at

 ---------> [email protected]

-----------------------------------------------------------------------

List of sections in this episode:

1. Genetic landscape  (1.43)

2.  Modifiable risk factors (27.13)

3. Diagnostic methods  (58.24)

-----------------------------------------------------------------------

This episode was curated and produced by a group of volunteers. As we work on producing full-length episodes on ALL the publications from June 2020, we would appreciate your feedback so we can better cater to your needs. 

You can fill our feedback form here 

---------->  https://forms.gle/5aq2JyrT6g4P1m8v6

You can also share your thoughts and suggestions by contacting us: 

• Email: [email protected]
• Twitter: @AMiNDR_podcast

-----------------------------------------------------------------------

Our music is from "Journey of a Neurotransmitter" by musician and fellow neuroscientist Anusha Kamesh; you can find the original piece and her other music on soundcloud under Anusha Kamesh or on her YouTube channel, AKMusic

https://www.youtube.com/channel/UCMH7chrAdtCUZuGia16FR4w

-----------------------------------------------------------------------

If you are interested in joining the team, send us your CV by email. We are specifically looking for help with abstract summary and podcast editing. However, if you are interested in helping in other ways, don't hesitate to apply anyways. 

-----------------------------------------------------------------------

*About AMiNDR: *

Learn more about this project and the team behind it by listening to our first episode: "Welcome to AMiNDR!"

-----------------------------------------------------------------------

Our next trial episodes for the month of February 2020: Treatments and Testing, Miscellaneous.